Bio-Rad Laboratories, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bio-Rad Laboratories, Inc. on December 10, 2020. The filing serves as a Regulation FD disclosure regarding an investor presentation and press release issued on the same date. The company is incorporated in Delaware and trades on the New York Stock Exchange under the symbols BIO and BIOb.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a conduit for external materials (Exhibits 99.1 and 99.2) rather than containing the financial data itself.
Material Changes
No material changes to financial performance or operations are detailed within the text of this Form 8-K. The report solely announces the availability of an investor presentation and press release.
Guidance, Outlook, and Management Commentary
Management commentary, guidance, and outlook are contained within the attached Investor Presentation (Exhibit 99.1) and Press Release (Exhibit 99.2), which are not included in the provided text. The filing explicitly states that the information in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review the attached Investor Presentation (Exhibit 99.1) for specific financial guidance and operational outlook.
- Read the Press Release (Exhibit 99.2) for details on the announcement made on December 10, 2020.
- Verify that the information in the presentation is not considered "filed" under Section 18 of the Exchange Act unless specifically referenced in other filings.
- Confirm the trading symbols (BIO, BIOb) and exchange (NYSE) for the company's Class A and Class B Common Stock.